The cervical disc replacement landscape just got a major upgrade. The FDA has officially granted premarket approval (PMA) for two-level indications for not one, but two total disc replacement (TDR) devices: the prodisc® C SK and prodisc® C Vivo.
That’s right — Centinel Spine, LLC has brought two more options for on cervical mobility to market, and the results are spine-tingling.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
